Lauren Sabella
Chief Operating Officer at MANNKIND CORPORATION
Net worth: 1 M $ as of 2024-03-30
Profile
Lauren M.
Sabella is the founder of Tugboat Consulting Group, which was founded in 2009.
She is currently the Chief Operating Officer & Executive Vice President at MannKind Corp.
since 2023.
Ms. Sabella's former positions include Chief Operating Officer at Acorda Therapeutics, Inc. from 2021 to 2022, Vice President-Commercial Development at Altus Pharmaceuticals, Inc. from 2006 to 2008, and Vice President-Sales-Eastern Zone at Boehringer Ingelheim Pharmaceuticals, Inc. from 2002 to 2006.
Ms. Sabella received an undergraduate degree from Hofstra University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
MANNKIND CORPORATION
0.09% | 2024-03-26 | 246,351 ( 0.09% ) | 1 M $ | 2024-03-30 |
| 2023-04-23 | 536 ( 0.04% ) | 7 081 $ | 2024-03-30 |
Lauren Sabella active positions
| Companies | Position | Start |
|---|---|---|
| MANNKIND CORPORATION | Chief Operating Officer | 2023-03-26 |
Former positions of Lauren Sabella
| Companies | Position | End |
|---|---|---|
| ACORDA THERAPEUTICS, INC. | Chief Operating Officer | 2022-09-29 |
| Tugboat Consulting Group | Founder | 2010-01-31 |
Altus Pharmaceuticals, Inc.
 Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Corporate Officer/Principal | 2008-09-29 |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Sales & Marketing | 2006-03-31 |
Training of Lauren Sabella
| Hofstra University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ACORDA THERAPEUTICS, INC. | Health Technology |
| MANNKIND CORPORATION | Health Technology |
| Private companies | 3 |
|---|---|
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Health Technology |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
| Tugboat Consulting Group |
- Stock Market
- Insiders
- Lauren Sabella
